26 February 2021
First Derivatives plc
("FD" or the "Company")
Issue of Equity
FD (AIM: FDP.L, Euronext Growth: FDP.I) announces that on 26 February 2021 the Company allotted 6,567 new ordinary shares of 0.5p each in the Company (the "Ordinary Shares") pursuant to the exercise of share options by certain employees.
Application has been made for the new Ordinary Shares to be admitted to trading on AIM and Euronext Growth and it is expected that admission will take place on 4 March 2021. The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following these allotments, the total issued share capital of the Company will increase to 27,717,324 ordinary shares.
Enquiries
For further information please contact:
| First Derivatives plc Seamus Keating, Chief Executive Officer Ryan Preston, Chief Financial Officer Ian Mitchell, Head of Investor Relations | +44(0)28 3025 2242 |
|
|
|
| Investec Bank plc (Nominated Adviser and Broker) Andrew Pinder Carlton Nelson Sebastian Lawrence | +44 (0)20 7597 5970 |
|
|
|
| Goodbody (Euronext Growth Adviser and Broker) David Kearney Don Harrington Finbarr Griffin
| +353 1 667 0420 |
|
|
|
About FD
FD is a global technology provider with more than 20 years of experience working with some of the world's largest finance, technology, automotive, manufacturing and energy institutions. The Group's Kx technology, incorporating the kdb+ time-series database, is a leader in high-performance, in-memory computing, streaming analytics and operational intelligence. Kx delivers the best possible performance and flexibility for high-volume, data-intensive analytics and applications across multiple industries. FD operates from 15 offices across Europe, North America and Asia Pacific, including its headquarters in Newry, and employs more than 2,400 people worldwide.
For further information, please visit www.firstderivatives.com and www.kx.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
